Skip to content

Microbot Medical MBOT Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$6.12M-11.6%$6.28M-5.2%$6.73M+16.4%$7.61M+42.9%$6.92M+31.2%
$5.31M
-$16.04M-30.8%-$14.74M-26.8%-$14.04M-36.8%-$13.47M-41.7%-$12.26M-31.6%
$1.83M+570%$1.29M+606%$649K+273%$450K+295%$273K+153%
-$14.21M-21.8%-$13.14M-14.8%-$13.07M-16.6%-$12.71M-21.8%-$11.67M-13.8%
-$0.26+60.0%-$0.29+60.8%-$0.45+43.8%-$0.58+28.4%-$0.65+27.0%
-$16M-31.3%-$14.7M-27.4%-$13.97M-37.5%-$13.4M-42.4%-$12.18M-32.3%
-$16.04M-30.8%-$14.74M-26.8%-$14.04M-36.8%-$13.47M-41.7%-$12.26M-31.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Microbot Medical's revenue?
Microbot Medical (MBOT) generated $190.2K in revenue over the trailing twelve months, up 62.4% year over year.
Is Microbot Medical profitable?
Microbot Medical is not currently profitable: it reported a net loss of $14.2M over the trailing twelve months, a -3669.9% net margin.
What is Microbot Medical's earnings per share?
Microbot Medical's diluted EPS over the trailing twelve months is $-0.26.
Where does Microbot Medical's income statement data come from?
Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.